Nymox Pharmaceutical Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
NYMXF Over the counter 8731 https://nymox.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Nymox Pharmaceutical Corp

Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages - Mar 27th, 2024 1:36 pm
Nymox December 27 Message to Shareholders - Dec 27th, 2023 3:13 pm
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others - Nov 30th, 2023 5:14 pm
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court - Nov 21st, 2023 4:42 pm
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million - Nov 9th, 2023 3:18 pm
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized - Nov 3rd, 2023 6:21 pm
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023 - Nov 3rd, 2023 2:05 pm
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations - Nov 2nd, 2023 1:59 pm
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting - Oct 31st, 2023 2:21 pm
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting - Oct 27th, 2023 8:00 pm
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review - Oct 26th, 2023 2:00 pm
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH - Sep 25th, 2023 1:42 pm
Nymox Reports Completion of $2 Million Private Placement - Aug 29th, 2023 5:14 pm
Nymox Announces $2 Million Private Placement - Aug 2nd, 2023 4:21 pm
Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO - Jul 31st, 2023 2:50 pm
Nymox Update - Jul 13th, 2023 2:16 pm
Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox - Jul 12th, 2023 1:30 pm